Patents by Inventor Mary Catherine Lessig

Mary Catherine Lessig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8084491
    Abstract: The subject invention provides methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising topiramate. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury.
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: December 27, 2011
    Assignee: Novodermix International Limited
    Inventors: Nathan Andrew Shapira, Mary Catherine Lessig, Daniel John Driscoll
  • Patent number: 7208477
    Abstract: The subject invention provides methods and compositions for the treatment of benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases. In the practice of the subject invention, and anti-convulsant agent, such as topiramate, is administered to an individual.
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: April 24, 2007
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Nathan Andrew Shapira, Mary Catherine Lessig, Bonnie I. McLaurin
  • Publication number: 20040191310
    Abstract: The subject invention provides methods and compositions for the treatment of benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases. In the practice of the subject invention, and anti-convulsant agent, such as topiramate, is administered to an individual.
    Type: Application
    Filed: December 1, 2003
    Publication date: September 30, 2004
    Inventors: Nathan Andrew Shapira, Mary Catherine Lessig, Bonnie I. McLaurin
  • Publication number: 20040067963
    Abstract: The subject invention provides methods for the treatment of ASD and/or PTSD comprising the administration of a dose of an SSRI taken soon after a trauma (for example, less than 48 hours and before the onset of ASD.
    Type: Application
    Filed: June 10, 2003
    Publication date: April 8, 2004
    Applicant: University of Florida
    Inventors: Nathan Andrew Shapira, Serena M. Galen, Mary Catherine Lessig
  • Publication number: 20020082222
    Abstract: The subject invention provides methods and compositions for the treatment of neurogenetic disorders, particularly DSM-IV impulse control disorders such as intermittent explosive disorder, kleptomania, pyromania, pathologic gambling, trichotillomania, and other impulse control disorders such as compulsive buying and problematic Internet use. In a preferred embodiment, the subject invention provides methods for treating or controlling symptoms associated with ADHD or PWS comprising the administration of therapeutically effective amounts of compositions containing compounds of the formulas I-V. In another embodiment, the subject invention provides for methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising the compounds of formulas I-V. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury.
    Type: Application
    Filed: November 30, 2001
    Publication date: June 27, 2002
    Inventors: Nathan Andrew Shapira, Mary Catherine Lessig, Daniel John Driscoll